Regulating the levels of key factors in cell cycle and DNA repair: New pathways revealed by lamins by Redwood, Abena B et al.




Regulating the levels of key factors in cell cycle and
DNA repair: New pathways revealed by lamins
Abena B. Redwood
Washington University School of Medicine in St. Louis
Ignacio Gonzalez-Suarez
Washington University School of Medicine in St. Louis
Susana Gonzalo
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Redwood, Abena B.; Gonzalez-Suarez, Ignacio; and Gonzalo, Susana, ,"Regulating the levels of key factors in cell cycle and DNA




Cell Cycle 10:21, 3652-3657; November 1, 2011; © 2011 Landes Bioscience
 extra view
3652 Cell Cycle volume 10 issue 21
contribute to genomic instability and that 
can be activated in disease states inde-
pendent of the status of A-type lamins.
Introduction
Lamin-related diseases are characterized 
by the presence of nuclear deformation, 
epigenetic alterations of chromatin and 
chromosomal aberrations.1,2 Most of the 
data on genomic instability has resulted 
from the study of cells from patients with 
Hutchinson-Gilford Progeria Syndrome 
(HGPS) and from mouse models of pro-
geria. The progeria phenotype arises 
from mutations that alter the normal 
processing and maturation of lamin A.3,4 
Accumulation of unprocessed lamin A 
species at the nuclear lamina causes the 
characteristic nuclear defects that lead to 
cell toxicity.5 Interestingly, progeria cells 
accumulate DNA DSBs,6,7 similar to cells 
of aged individuals,7,8 indicating a compro-
mised DNA repair system. However, no 
clear defects in repair proteins themselves 
or in the activation of the DNA dam-
age response (DDR) pathway have been 
observed in progeria cells.9 One excep-
tion is the observed accumulation of the 
protein XPA (Xeroderma pigmentosum 
group A) at DSBs10 which was associated 
with impaired recruitment of key DNA 
repair factors such as Rad50, Rad51 and 
53BP1 to the breaks. Binding of XPA also 
activates ATM- and ATR-dependent sig-
naling cascades that arrest the cell cycle. 
However, depletion of XPA in progeria 
cells only partially restored the recruit-
ment of DNA repair factors to DSBs, 
indicating that additional mechanisms 
contribute to the DNA repair deficiencies 
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Spatial and temporal organization of the genome represents an additional 
step in the regulation of nuclear func-
tions. The nuclear lamina, a polymeric 
meshwork formed by lamins (A/C and 
B type) and lamin-associated proteins, 
plays a key role in the maintenance 
of genome localization, structure and 
function. Specifically, mutations in the 
LMNA gene encoding lamins A/C or 
changes in its expression, either upregu-
lation or silencing, are associated with 
defects in DNA replication, transcrip-
tion and repair, as well as alterations in 
epigenetic modifications of chromatin. 
These data, together with the fact that 
defects in A-type lamins are associated 
with a whole variety of degenerative dis-
orders, premature aging syndromes and 
cancer, support the notion that these 
proteins operate as caretakers of the 
genome. However, our understanding of 
their functions is limited due to the lack 
of well-defined mechanisms behind the 
genomic instability observed in lamin-
related diseases. Here, we summarize our 
recent discovery of new pathways that 
are affected by the loss of A-type lam-
ins. In particular, we found that A-type 
lamins control transcription and degra-
dation of proteins with key roles in cell 
cycle regulation and DNA double-strand 
breaks (DSBs) repair by nonhomologous 
end-joining (NHEJ) and homologous- 
recombination (HR). Importantly, the 
proteins regulated by A-type lamins—
Rb family members, 53BP1, BRCA1 and 
RAD51— exert tumor suppressor func-
tions, with their loss being associated 
with cancer susceptibility. Moreover, 
our studies revealed novel pathways that 
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at a much lower intensity. These results are 
highly relevant, since 53BP1 is an impor-
tant player in long-range end-joining 
processes such as class-switch and V(D)J 
recombination, as well as in the joining of 
dysfunctional telomeres.22-25 In addition, 
53BP1 is thought to play a role in the repair 
of short-range DNA DSBs by binding to 
the breaks, inhibiting end-resection and 
facilitating the recruitment of the NHEJ 
DNA repair machinery.26,27 These data, 
together with the fact that 53BP1-deficient 
cells exhibit increased genomic instabil-
ity and radiosensitivity28-31 suggested that 
the loss of 53BP1 could be responsible 
for the DNA repair deficiencies observed 
in Lmna-KO cells. Consistent with our 
hypothesis, we found that lamins-deficient 
cells treated with ionizing radiation exhibit 
profound defects in the fast phase of DNA 
DSBs repair.19,32 Fast repair is tradition-
ally associated with C-NHEJ, since simi-
lar defects are observed upon depletion or 
mutation of essential factors in this pro-
cess such as DNA-PK, Ku80, XRCC4 and 
DNA ligase IV.16 Furthermore, lamins- 
deficient cells are defective in the processing 
when the damage cannot be repaired by 
NHEJ that end-resection is promoted and 
additional mechanisms undertake DNA 
repair. Besides HR and C-NHEJ, a less 
understood pathway, alternative nonho-
mologous end-joining (A-NHEJ),16,17 is 
sometimes used as a backup repair path-
way. A-NHEJ involves processing of DNA 
by end-resection to reveal regions of short 
microhomology which are then ligated. 
In contrast to HR, resected DNA is not 
filled in during A-NHEJ, making it a 
potentially more deleterious process than 
both C-NHEJ and HR. In line with this 
notion, A-NHEJ is associated with high 
frequencies of chromosomal transloca-
tions and genomic instability.
Lamins Role  
in DNA DSBs Repair by NHEJ
Our studies have provided strong evidence 
for a role of A-type lamins in the main-
tenance of DNA repair mechanisms and 
telomere homeostasis. We found that loss 
of A-type lamins leads to sustained DNA 
damage signaling as measured by forma-
tion of γH2AX foci, as well as an increase 
in aneuploidy, chromosomal abnormali-
ties and telomere shortening/loss.18-21 
Furthermore, loss of these structural 
proteins was associated with alterations 
in the nuclear organization of chromo-
somes, such that the distribution of telo-
meres was shifted toward the periphery 
of the nucleus.18,21 Despite the increase 
in genomic instability, and similar to 
what was reported in progeria cells, loss 
of A-type lamins does not impair activa-
tion of the DNA damage response (DDR) 
when cells are exposed to ionizing radia-
tion.19 ATM-dependent phosphorylation 
of H2AX (γH2AX) and p53 at Ser15 was 
not affected in Lmna-KO mouse embry-
onic fibroblasts (MEFs), and the kinetics 
of formation and resolution of γH2AX 
ionizing radiation-induced foci (IRIF) 
was indistinguishable between lamins-
deficient and -proficient cells. In contrast, 
lamins-deficient cells show defective accu-
mulation of 53BP1 at IRIF at all post-
irradiation times tested.19 Importantly, 
we found that this deficiency is due to a 
marked decrease in the global levels of the 
53BP1 protein, and not to failed recruit-
ment, since 53BP1 IRIF formed although 
in these cells. Interestingly, a recent report 
demonstrated the absence of the nuclear 
DNA-PK holoenzyme in premature as 
well as physiological aging.11 These studies 
have started to shed some light into puta-
tive molecular mechanisms that could be 
impacted upon by alterations in A-type 
lamins function. We have undertaken a 
loss-of-function approach to gain a deeper 
understanding of the role that A-type lam-
ins play in the maintenance of genomic 
stability. We found that loss of A-type 
lamins leads to the downregulation of a 
number of factors with key roles in cell 
cycle regulation, e.g., Rb family mem-
bers and DNA DSBs repair, e.g., 53BP1, 
BRCA1 and RAD51. We will summarize 
here the molecular mechanisms behind 
the regulation of these factors by A-type 
lamins and their significance for under-
standing aging-related diseases.
Mechanisms of DNA DSBs Repair
Repair of damaged DNA is critical for 
maintenance of genomic stability. Among 
the various types of DNA damage, DSBs 
are the most deleterious, leading to muta-
tions, loss of genomic material and trans-
locations if not properly repaired. The two 
major pathways of DSBs repair, homolo-
gous recombination (HR) and classic 
nonhomologous end-joining (C-NHEJ) 
are considered to compete for repair sub-
strate and be mutually exclusive.12-14 HR 
is error-free and requires both resection 
of the 5' DNA ends around the break and 
the presence of a homologous template. In 
contrast, C-NHEJ involves end ligation of 
damaged DNA and requires neither exten-
sive resection nor homologous templates. 
C-NHEJ is a fast and error-prone mecha-
nism which can cause translocations and/
or loss of genetic material. While C-NHEJ 





 stages of the cell cycle, when the 
lack of the sister chromatid prevents HR 
from being activated, the slower HR repair 
mechanism has traditionally been thought 
to dominate during S and G
2
 phases of the 
cell cycle. However, recent evidence15 has 
challenged the notion of HR dominance 
in S/G
2
, suggesting that the need for rapid 
DNA damage repair makes NHEJ the 
preferred pathway even when HR is pos-
sible. According to this data, it is only 
Figure 1. regulation of rb family members 
by CtSL. Blots showing that overexpres-
sion of CtSL via retroviral transduction of 
wild-type MeFs leads to downregulation of 
the pocket proteins prb and p107 but has no 
effect in the levels of p130. as a control for 
increased CtSL activity, we show decreased 
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levels of CTSL mRNA.40 Although this 
suggested a relationship between CTSL 
and the aging phenotype, no association 
was established between CTSL and the 
increase in genomic instability displayed 
by these mice. Our studies showed that 
Lmna-KO cells exhibit a marked increase 
in the levels of CTSL mRNA and pro-
tein, indicating that loss of A-type lamins 
induces transcriptional upregulation of 
CTSL.32 Furthermore, we demonstrated 
that the increase in CTSL is directly 
responsible for the downregulation of 
53BP1 protein levels. Depletion of CTSL 
via lentiviral transduction with a specific 
shRNA restored 53BP1 protein levels and 
rescued NHEJ defects in lamins-deficient 
cells. Moreover, transduction with both 
53BP1 and CTSL shRNAs in this context 
prevented restoration of NHEJ, demon-
strating that the recovery is brought about 
by stabilization of 53BP1.
The regulatory effect of CTSL on 
53BP1, and thus in DNA repair is not 
restricted to lamins-deficient cells. 
Overexpression of CTSL in wild-type cells 
is sufficient to lower the levels of 53BP1 
and impair repair by NHEJ.32 This is a 
autoproteolytic processing within the 
lysosomal/endosomal compartment to 
release the mature active form.33 Though 
its activity is enhanced by the low pH at 
the lysosome, CTSL can also be found in 
other cellular organelles, where it can selec-
tively process other targets at less acidic or 
even neutral environments. CTSL can be 
secreted to the extracellular matrix where 
it is known to degrade some of its compo-
nents under physiological conditions, i.e., 
favoring bone resorption in osteoclasts.34 
Increased extracellular CTSL has been 
reported in numerous types of cancer and 
is often associated with increased invasive-
ness and metastasis.35-37 More recently, 
CTSL was found inside the nucleus, where 
in a more regulated fashion, it processes 
specific nuclear components such as his-
tone H3 tails during stem cell differen-
tiation and the transcription factor CDP/
Cux during cell cycle progression.38,39
The first link between CTSL and 
A-type lamins was established in a mouse 
model of progeria. In particular, mice 
lacking Zmpste24, a metalloprotease 
that participates in the maturation of 
lamin A, exhibit a drastic increase in the 
of dysfunctional telomeres by NHEJ. 
Importantly, we found that reconstitution 
of 53BP1 in lamins-deficient cells rescues 
the defects in NHEJ of DNA DSBs and 
dysfunctional telomeres.19 Overall, these 
results revealed that 53BP1 deficiency is a 
major contributor of the DNA repair phe-
notype observed in lamins-deficient cells. 
This is a critical observation, since many 
studies rely on foci formation to determine 
whether a step in the DDR is functional. 
Our results indicate that it is important 
to monitor the levels of DDR proteins at 
DSBs when assessing deficiencies in DNA 
repair.
How are the Levels of 53BP1 
Regulated by A-Type Lamins?
During our exploration of mechanisms by 
which A-type lamins affect DNA DSBs 
repair we discovered a role for cathepsin 
L (CTSL) in the stability of 53BP1 pro-
tein. CTSL is a cysteine protease from 
the papain family that is ubiquitously 
expressed in mouse and human tissues. 
Like many other proteases, it is synthe-
sized as a zymogen which undergoes 
Figure 2. vitamin D-dependent inhibition of CtSL activity may be mediated by cystatins. (a) Promoter analysis for vitamin D responding elements 
(vDres) in the 13 cystatins encoded in the mouse genome resulted in four candidate genes containing at least two rxr/vDr heterodimer binding 
sites. (B) qrt-PCr experiments show that cystatin B expression is downregulated in lamins-deficient cells. treatment with vitamin D 10-7 M for 48 h in-
creases cystatin B expression in both wild-type and Lmna-KO MeFs. values are expressed as mean ± SeM. N, the number of independent experiments; 
*, p value of statistical significance (p ≤ 0.05); r. U., relative units (normalization to GaPDH).
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complexes.19 These data suggest activa-
tion of a similar repressive mechanism in 
lamins-deficient cells, where altering the 
balance of the pocket proteins might favor 
association of p130 with E2F4, leading to 
transcriptional inhibition of responsive 
promoters. However, we cannot rule out 
the possibility that loss of A-type lamins 
leads to alterations in the nuclear localiza-
tion of BRCA1 and RAD51 genes, which 
might contribute to their transcriptional 
repression.
It is well established that pocket pro-
teins associate with lamins and that loss of 
A-type lamins leads to increased degrada-
tion of pRb and to a lesser extent p107.44,45 
This is thought to occur partly through 
the ability of A-type lamins to regulate the 
sub-nuclear localization of these proteins. 
However, the specific mechanism by which 
pRb and p107 are targeted for degradation 
remains quite elusive, being independent 
reduction in expression of two key factors 
in this process, BRCA1 and RAD51. In 
contrast to the CTSL-mediated degrada-
tion of 53BP1, decreased levels of BRCA1 
and RAD51 are brought about by tran-
scriptional gene repression.19 Previous 
reports had demonstrated transcriptional 
repression of BRCA1 and RAD51 under 
certain stressful conditions, such as 
hypoxia or PARP inhibition, via forma-
tion of p130/E2F4 complexes at E2F sites 
within their promoters.42,43 Interestingly, 
in the context of lamin A/C-deficiency, 
we also find that repression of BRCA1 and 
RAD51 genes is linked to the status of the 
Rb family of tumor suppressors, pRb, p107 
and p130, such that repression of BRCA1 
and RAD51 requires p130 and occurs in 
the context of pRb and p107 deficiency. 
Furthermore, co-immunoprecipitation 
studies in cells depleted of A-type lam-
ins showed an increase in p130/E2F4 
very relevant result because a great variety 
of tumors present with high CTSL expres-
sion. Our studies suggest that in addi-
tion to the previously reported effects of 
CTSL upregulation on the degradation of 
extracellular matrix components and cell- 
adhesion molecules, CTSL upregulation 
in cancer could inhibit mechanisms of 
DNA repair. Future studies need to deter-
mine whether upregulation of CTSL activ-
ity is a novel mechanism contributing to 
genomic instability in cancer, which could 
be targeted with therapeutic purposes.
Lamins Role  
in DNA DSBs Repair by HR
Loss of 53BP1 favors repair of DNA DSBs 
by HR.27,41 However, despite decreased 
53BP1 levels, HR is suppressed upon 
depletion of A-type lamins.19 This inhibi-
tion of HR is explained by the significant 
Figure 3. Proposed model for the regulation of DNa repair mechanisms by a-type lamins. the loss of a-type lamins upregulates CtSL expression, 
resulting in elevated protein levels both in the nucleus and in the lysosomes. CtSL processes 53BP1, which then accumulates in the cytoplasm and 
is targeted to degradation by the lysosomal pathway and/or the proteasome. Loss of 53BP1 impairs DNa repair by NHeJ. On the other hand, CtSL 
degrades the pocket family proteins prB and p107, favoring the formation of p130/e2F4 repression complexes, which in turn inhibit raD51 and BrCa1 
gene expression and thereby impair DNa repair by Hr.
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family member. Since there is no mouse 
ortholog for cystatin D, we performed a 
promoter analysis for vitamin D respon-
sive elements (VDRE) in the 13 cystatin 
genes encoded by the mouse genome. 
We used the Genomatix software and 
ElDorado mouse genome database. In 
the initial analysis we selected 4 cystatin 
genes which contain at least two RXR/
VDR heterodimer binding sites (Fig. 2A). 
One of them, cystatin B (also known as 
Stefin B) contains four VDR responding 
elements (human cystatin D contains five 
elements) and is downregulated in lamin 
deficient-cells. Moreover, treatment with 
vitamin D increases the expression of cys-
tatin B (Fig. 2B), suggesting a role in the 
regulation of CTSL activity. Nevertheless, 
additional studies will be necessary to fully 
determine which cystatin(s) is responsible 
for the vitamin D-dependent inhibition of 
CTSL activity.
Conclusions
Our findings support a fundamental 
role for CTSL in the regulation of cell 
cycle progression and DNA repair, both 
in lamin-deficient and -proficient cells. 
Upregulation of CTSL, a hallmark of 
a variety of cancers, is directly linked to 
degradation of Rb family members and 
53BP1 and possibly indirectly to tran-
scriptional downregulation of BRCA1 
and RAD51 (Fig. 3). Thus, inhibition 
of CTSL activity via treatment with vita-
min D or specific inhibitors could repre-
sent a novel approach in the management 
of cancer and other age-related diseases 
that course with increased genomic insta-
bility and defects in DNA repair.
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